Bruker Corporation
- https://www.bruker.com
- info@bruker.com
- +1-978-663-3660
- Bruker Daltonics and Optics, 40, Manning Road, Nutting Lake, Billerica, Middlesex County, Massachusetts, 01821, United States


Mass General Brigham (formerly Partners HealthCare), based in Boston, Massachusetts, is a colossal, globally renowned integrated academic healthcare system that serves as the primary teaching affiliate for Harvard Medical School. Founded in 1994 by the historic merger of two monumental institutions—Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH)—the system represents one of the most profound concentrations of medical and scientific expertise on the planet.
Operating on a massive scale, Mass General Brigham employs over 85,000 people and serves more than 2 million unique patients annually. The organization operates the absolute largest hospital-based research enterprise in the United States, commanding an annual research budget exceeding $2.7 billion. Their massive, sprawling research laboratories are deeply engaged in highly advanced genomics, proteomics, immunology, oncology, and neuroscience, actively pushing the very boundaries of human medical knowledge.
The institution is universally famous for bridging the critical gap between deep academic science and direct clinical application, currently managing over 3,700 ongoing clinical trials. MGH and BWH have been the historic sites of countless medical firsts, including the first public demonstration of surgical anesthesia, the first successful human organ transplant, and pioneering FDA-approved gene therapies.
Beyond its massive research and clinical footprint, Mass General Brigham operates its own health insurance plan and university of health professions, deeply integrating every aspect of care delivery and medical education. By uniquely combining the vast clinical resources of a massive health network with the unparalleled academic rigor of Harvard University, Mass General Brigham stands as a dominant, indispensable engine driving global biomedical innovation and elite patient care.